Nurix Therapeutics Correlations

NRIX Stock  USD 11.63  0.38  3.38%   
The current 90-days correlation between Nurix Therapeutics and C4 Therapeutics is 0.38 (i.e., Weak diversification). The correlation of Nurix Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Nurix Therapeutics Correlation With Market

Weak diversification

The correlation between Nurix Therapeutics and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Nurix Stock please use our How to Invest in Nurix Therapeutics guide.

Moving together with Nurix Stock

  0.73VRDN Viridian TherapeuticsPairCorr
  0.65VTYX Ventyx BiosciencesPairCorr
  0.64MRK Merck Company Earnings Call This WeekPairCorr
  0.63PFE Pfizer IncPairCorr
  0.76NUVL NuvalentPairCorr
  0.78ACLX ArcellxPairCorr
  0.64SEER Seer IncPairCorr
  0.62PTAIF PT Astra International Earnings Call This WeekPairCorr

Moving against Nurix Stock

  0.55MCD McDonaldsPairCorr
  0.42TRV The Travelers CompaniesPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FHTXCCCC
ITOSKYMR
RLAYKYMR
RLAYFHTX
RLAYCCCC
ITOSIPSC
  
High negative correlations   
RVMDFHTX
RLAYRVMD
ITOSRVMD
RVMDCCCC

Risk-Adjusted Indicators

There is a big difference between Nurix Stock performing well and Nurix Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nurix Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Nurix Therapeutics Corporate Management

Stefani WolffCOO DevelProfile
Paula MDChief OfficerProfile
Christopher PhelpsSenior DiscoveryProfile
Christine JDSecretary OfficerProfile
John KuriyanFounder BoardProfile
JD EsqVP CounselProfile